98 related articles for article (PubMed ID: 10049647)
1. Identification of genes involved in innate responsiveness to bacterial products by differential display.
Jin F; Nathan C; Ding A
Methods; 1998 Dec; 16(4):396-406. PubMed ID: 10049647
[TBL] [Abstract][Full Text] [Related]
2. [Effects of secretory leukocyte protease inhibitor on the production of some cytokines and nitric oxide by murine peritoneal macrophages in response to lipopolysaccharide stimulation and M. avium complex infection].
Sano C; Shimizu T; Sato K; Ogasawara K; Tomioka H
Kekkaku; 1999 Jul; 74(7):563-70. PubMed ID: 10481411
[TBL] [Abstract][Full Text] [Related]
3. Secretory leukocyte protease inhibitor: a macrophage product induced by and antagonistic to bacterial lipopolysaccharide.
Jin FY; Nathan C; Radzioch D; Ding A
Cell; 1997 Feb; 88(3):417-26. PubMed ID: 9039268
[TBL] [Abstract][Full Text] [Related]
4. Paradoxical preservation of a lipopolysaccharide response in C3H/HeJ macrophages: induction of matrix metalloproteinase-9.
Jin F; Nathan CF; Ding A
J Immunol; 1999 Mar; 162(6):3596-600. PubMed ID: 10092819
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of inducible nitric-oxide synthase expression by (5R)-5-hydroxytriptolide in interferon-gamma- and bacterial lipopolysaccharide-stimulated macrophages.
Zhou R; Zheng SX; Tang W; He PL; Li XY; Yang YF; Li YC; Geng JG; Zuo JP
J Pharmacol Exp Ther; 2006 Jan; 316(1):121-8. PubMed ID: 16166270
[TBL] [Abstract][Full Text] [Related]
6. Requirement for STAT1 in LPS-induced gene expression in macrophages.
Ohmori Y; Hamilton TA
J Leukoc Biol; 2001 Apr; 69(4):598-604. PubMed ID: 11310846
[TBL] [Abstract][Full Text] [Related]
7. Suppression of macrophage responses to bacterial lipopolysaccharide (LPS) by secretory leukocyte protease inhibitor (SLPI) is independent of its anti-protease function.
Yang J; Zhu J; Sun D; Ding A
Biochim Biophys Acta; 2005 Sep; 1745(3):310-7. PubMed ID: 16112212
[TBL] [Abstract][Full Text] [Related]
8. The secretory leukocyte protease inhibitor is a type 1 insulin-like growth factor receptor-regulated protein that protects against liver metastasis by attenuating the host proinflammatory response.
Wang N; Thuraisingam T; Fallavollita L; Ding A; Radzioch D; Brodt P
Cancer Res; 2006 Mar; 66(6):3062-70. PubMed ID: 16540655
[TBL] [Abstract][Full Text] [Related]
9. Suppression of macrophage responses to bacterial lipopolysaccharide by a non-secretory form of secretory leukocyte protease inhibitor.
Zhu J; Nathan C; Ding A
Biochim Biophys Acta; 1999 Sep; 1451(2-3):219-23. PubMed ID: 10556576
[TBL] [Abstract][Full Text] [Related]
10. Lipopolysaccharide-related stimuli induce expression of the secretory leukocyte protease inhibitor, a macrophage-derived lipopolysaccharide inhibitor.
Jin F; Nathan CF; Radzioch D; Ding A
Infect Immun; 1998 Jun; 66(6):2447-52. PubMed ID: 9596701
[TBL] [Abstract][Full Text] [Related]
11. Identification of the secretory leukocyte protease inhibitor (SLPI) as a target of IRF-1 regulation.
Nguyen H; Teskey L; Lin R; Hiscott J
Oncogene; 1999 Sep; 18(39):5455-63. PubMed ID: 10498899
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory effect of naringin on lipopolysaccharide (LPS)-induced endotoxin shock in mice and nitric oxide production in RAW 264.7 macrophages.
Kanno S; Shouji A; Tomizawa A; Hiura T; Osanai Y; Ujibe M; Obara Y; Nakahata N; Ishikawa M
Life Sci; 2006 Jan; 78(7):673-81. PubMed ID: 16137700
[TBL] [Abstract][Full Text] [Related]
13. Regulation of macrophage chemokine expression by lipopolysaccharide in vitro and in vivo.
Kopydlowski KM; Salkowski CA; Cody MJ; van Rooijen N; Major J; Hamilton TA; Vogel SN
J Immunol; 1999 Aug; 163(3):1537-44. PubMed ID: 10415057
[TBL] [Abstract][Full Text] [Related]
14. Temporal induction of secretory leukocyte protease inhibitor (SLPI) in odontoblasts by lipopolysaccharide and wound infection.
Choi BD; Jeong SJ; Wang G; Kim HJ; Kim BO; Hwang HK; Lim DS; Kim SH; Jeong MJ
J Endod; 2009 Jul; 35(7):997-1002. PubMed ID: 19567322
[TBL] [Abstract][Full Text] [Related]
15. Nitric oxide modulates pro- and anti-inflammatory cytokines in lipopolysaccharide-activated macrophages.
Wu CH; Chen TL; Chen TG; Ho WP; Chiu WT; Chen RM
J Trauma; 2003 Sep; 55(3):540-5. PubMed ID: 14501900
[TBL] [Abstract][Full Text] [Related]
16. Neuroprotective effects of cyclooxygenase-2 inhibitor celecoxib against toxicity of LPS-stimulated macrophages toward motor neurons.
Huang Y; Liu J; Wang LZ; Zhang WY; Zhu XZ
Acta Pharmacol Sin; 2005 Aug; 26(8):952-8. PubMed ID: 16038627
[TBL] [Abstract][Full Text] [Related]
17. Effect of toll-like receptor (TLR) agonists on TLR and microbicide expression in uterine and vaginal tissues of the mouse.
Soboll G; Schaefer TM; Wira CR
Am J Reprod Immunol; 2006 Jun; 55(6):434-46. PubMed ID: 16674601
[TBL] [Abstract][Full Text] [Related]
18. Molecular mechanisms of natural resistance to mycobacterial infections.
Radzioch D; Kramnik I; Skamene E
Circ Shock; 1994 Nov; 44(3):115-20. PubMed ID: 7600634
[TBL] [Abstract][Full Text] [Related]
19. Differential anti-inflammatory pathway by xanthohumol in IFN-gamma and LPS-activated macrophages.
Cho YC; Kim HJ; Kim YJ; Lee KY; Choi HJ; Lee IS; Kang BY
Int Immunopharmacol; 2008 Apr; 8(4):567-73. PubMed ID: 18328448
[TBL] [Abstract][Full Text] [Related]
20. The role of STAT1/IRF-1 on synergistic ROS production and loss of mitochondrial transmembrane potential during hepatic cell death induced by LPS/d-GalN.
Lee HJ; Oh YK; Rhee M; Lim JY; Hwang JY; Park YS; Kwon Y; Choi KH; Jo I; Park SI; Gao B; Kim WH
J Mol Biol; 2007 Jun; 369(4):967-84. PubMed ID: 17475277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
